These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 20577964)
1. [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers]. Bürki N Ther Umsch; 2010 Jul; 67(7):359-66. PubMed ID: 20577964 [TBL] [Abstract][Full Text] [Related]
2. Familial breast and ovarian cancers. Arai M; Utsunomiya J; Miki Y Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703 [TBL] [Abstract][Full Text] [Related]
3. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses. Brunsvold AN; Wung SF; Merkle CJ J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160 [TBL] [Abstract][Full Text] [Related]
4. [Clinical and molecular diagnosis of inherited breast-ovarian cancer]. Chompret A J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301 [TBL] [Abstract][Full Text] [Related]
5. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Scheuer L; Kauff N; Robson M; Kelly B; Barakat R; Satagopan J; Ellis N; Hensley M; Boyd J; Borgen P; Norton L; Offit K J Clin Oncol; 2002 Mar; 20(5):1260-8. PubMed ID: 11870168 [TBL] [Abstract][Full Text] [Related]
6. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
7. A new paradigm of genetic testing for hereditary breast/ovarian cancers. Kwong A; Chen JW; Shin VY Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575 [TBL] [Abstract][Full Text] [Related]
8. Impact of Implementing B-RST Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475 [TBL] [Abstract][Full Text] [Related]
9. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675 [TBL] [Abstract][Full Text] [Related]
10. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Robson ME Cancer Control; 2002; 9(6):457-65. PubMed ID: 12514563 [TBL] [Abstract][Full Text] [Related]
11. Hereditary breast and ovarian cancer: review and future perspectives. Lux MP; Fasching PA; Beckmann MW J Mol Med (Berl); 2006 Jan; 84(1):16-28. PubMed ID: 16283147 [TBL] [Abstract][Full Text] [Related]
12. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol; 2009 Apr; 113(4):957-966. PubMed ID: 19305347 [TBL] [Abstract][Full Text] [Related]
13. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience. Maheu C; Thorne S Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940 [TBL] [Abstract][Full Text] [Related]
14. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727 [TBL] [Abstract][Full Text] [Related]
15. [A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition]. Bonaïti B; Alarcon F; Bonadona V; Pennec S; Andrieu N; Stoppa-Lyonnet D; Perdry H; Bonaïti-Pellié C; Bull Cancer; 2011 Jul; 98(7):779-95. PubMed ID: 21708517 [TBL] [Abstract][Full Text] [Related]
16. Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer. Antonucci I; Provenzano M; Sorino L; Balsamo M; Aceto GM; Battista P; Euhus D; Cianchetti E; Ballerini P; Natoli C; Palka G; Stuppia L J Hum Genet; 2017 Mar; 62(3):379-387. PubMed ID: 27928164 [TBL] [Abstract][Full Text] [Related]
17. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443 [TBL] [Abstract][Full Text] [Related]
18. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
19. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933 [TBL] [Abstract][Full Text] [Related]
20. [Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]. Theodor L; Shiri-Sverdlov R; Yechezkel GH; Bar-Sade RB; Gak E; Friedman I; Kruglikova A; Ben-Baruch G; Risel S; Papa MZ; Goldman B; Friedman E Harefuah; 1998 Apr; 134(8):593-9, 672. PubMed ID: 10911419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]